Pancleus (Pantoprazole)

Pantoprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related conditions.

• Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of erosive esophagitis.
• Erosive gastritis and duodenal ulcers: supports ulcer healing by maintaining a less acidic gastric environment.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with this rare neuroendocrine tumor.

• Pantoprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By binding covalently to the pump in its active state, it blocks the final step of acid production, leading to a sustained increase in gastric pH and reduction of acid‑related damage.

Adverse reactions reported with pantoprazole vary in frequency and severity.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Nausea or abdominal discomfort.
• Flatulence: excess gas production.
• Constipation: reduced bowel movements.
• Dizziness: occasional light‑headedness.

Serious or Rare Side Effects

• Clostridioides difficile‑associated colitis: severe intestinal infection.
• Acute interstitial nephritis: inflammation of kidney interstitium.
• Severe hypersensitivity reactions: rash, angioedema, anaphylaxis.
• Osteoporosis‑related fractures: increased risk with long‑term use.
• Hepatic dysfunction: elevated liver enzymes or hepatitis.
• Vitamin B12 deficiency: reduced absorption with prolonged therapy.

Before initiating therapy, consider patient‑specific factors and monitor appropriately.

• Assess renal function: dose adjustment may be required in severe impairment.
• Evaluate hepatic status: use with caution in moderate to severe liver disease.
• Review concomitant medications: potential for interaction with drugs requiring gastric acidity.
• Monitor long‑term users: watch for bone density loss and magnesium levels.
• Pregnancy and lactation: prescribe only if benefits outweigh potential risks.
• Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Pantoprazole may alter the absorption or metabolism of several medicines; clinical relevance varies.

Major Interactions (Avoid)

• Antiretroviral protease inhibitors (e.g., atazanavir): reduced plasma concentrations.
• Tyrosine kinase inhibitors (e.g., erlotinib): decreased efficacy due to higher gastric pH.
• Ketoconazole and other oral antifungals: markedly reduced absorption.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR; monitor coagulation.
• Methotrexate (high‑dose): reduced renal clearance; check serum levels.
• Digoxin: slight increase in serum concentration; observe for toxicity.
• Clopidogrel: potential reduction in antiplatelet effect; consider alternative therapy.